Aida Muncada, MD

Results 1 - 6 of 6
Public Title Project Description Modified
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Ev . . . This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the effi . . . 09 Aug 2016 09:33:49
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety . . . This is an open-label, 104-week, multicenter, extension study designed to evaluate the long-term saf . . . 08 Dec 2016 03:23:29
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study To Evalu . . . This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the effi . . . 09 Aug 2016 09:30:44
Confirmatory Study of DSP-5423P in Patients with Schizophrenia (Phase 3) The study consists of 4 phases: the washout phase, the double-blind treatment phase, the open-label . . . 20 Aug 2018 04:17:37
A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFI . . . This will be a Phase 3, multicenter, 4-week, randomized, double-blind, placebo-controlled, parallel- . . . 11 Jul 2019 10:44:43
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral . . . This protocol describes a 6-month, open label extension study (A1281201) of the A1281198 study. This . . . 11 Jul 2019 10:51:16

Copyright © One Window Project 2018. All rights reserved.